MedTrace Logo

Development and Validation of a Serum Biomarker for the Diagnostic Work-up of Asthma

NCT04377958 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2020-05-08

No results posted yet for this study

Summary

Serum samples of asthmatic patients will be screened for serum biomarkers

Conditions

Interventions

DIAGNOSTIC_TEST

Serum biomarker testing

Serum and sputum samples will be collected and biomarkers will be evaluated using ELISA

Sponsors & Collaborators

  • KU Leuven

    lead OTHER

Principal Investigators

  • Lieven Dupont · UZ Leuven

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-10-31
Completion
2020-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04377958 on ClinicalTrials.gov